Lv21
195 积分 2021-08-04 加入
A PTK7-targeted antibody-drug conjugate reduces tumor-initiating cells and induces sustained tumor regressions
4小时前
待确认
Receptor CDCP1 is a potential target for personalized imaging and treatment of poor outcome HER2+, triple negative and metastatic ER+/HER2- breast cancers
5天前
已完结
CDCP1: A promising diagnostic biomarker and therapeutic target for human cancer
5天前
已完结
The CDCP1 Signaling Hub: A Target for Cancer Detection and Therapeutic Intervention
5天前
已完结
Discovery of a new anti-γc antibody in clinical development for the treatment of autoimmune diseases
12天前
已完结
Crystal structure of CD38 in complex with daratumumab, a first-in-class anti-CD38 antibody drug for treating multiple myeloma
15天前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
27天前
已完结
Structural Biology of the Cell Adhesion Protein CD2: From Molecular Recognition to Protein Folding and Design
1个月前
已完结
Safety Profile, Pharmacokinetics, and Pharmacodynamics of Siplizumab, A Humanized Anti-CD2 Monoclonal Antibody, in Renal Allograft Recipients
1个月前
已完结
SELECTIVE DELETION OF ANTIGEN-SPECIFIC, ACTIVATED T CELLS BY A HUMANIZED MAB TO CD2 (MEDI-507) IS MEDIATED BY NK CELLS
1个月前
已完结
皖公网安备34019202002308
